The Gross Margin of Medite Cancer Diagnostics Inc (MDIT) is 2.38%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2017-12-31 | 2.38% |
| 2016-12-31 | 39.29% |
| 2015-12-31 | 38.46% |
| 2014-12-31 | 34.77% |
| 2013-12-31 | 42.30% |
| 2012-12-31 | 47.47% |
| 2011-12-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2008-12-31 | 30.77% |